The size of the Europe Peripheral Intravenous Catheters Market was around USD 1.39 billion in 2024. It is expected to grow at a CAGR of 5.6% to reach USD 1.83 billion by 2029. It captures 27% of the global market.
The rising elder people population is accelerating the demand of the market. The rise in chronic diseases like cancer, stroke, diabetes, upgraded healthcare system, and favorable reimbursement structures mount the PIVC market growth in this region. A growing number of surgery cases, availability of upgraded catheters, and increasing awareness among the people population are expected to surge the PIVC market growth during the analysis period.The cost associated with the peripheral intravenous catheters is so expensive, which is unaffordable by some small hospitals is restricting the market. Lack of trained and experienced professionals required to use these peripheral IV catheters is restraining the growth. Safety issues regarding the utilization of PIVC like different infections will obstruct the market.
Short PIVC (Ported Peripheral Intravenous Catheter and Non-ported Peripheral Intravenous Catheter) and Integrated/Closed PIVC
Integrated/Closed catheters and Peripheral insertion catheters
Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Home Use and Others
Conventional Peripheral Intravenous Catheter and Safety Peripheral Intravenous Catheter
United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe
Europe was the second-largest in the global PIVC market. The escalating aging population, huge expenses on healthcare, and advanced technologies resulting in a high surgical procedure rate propel the PIVC market growth during the analysis period. The UK is governing the market with a surge in an unhealthy lifestyle; age-related factors add people prone to chronic diseases. Growth in parenteral drug approvals and a rise in biological drugs obtainable in injectable forms are fueling the growth. Germany followed after the UK is leading the market due to the growing large number of hospitals, which accounts for maximum revenue growth, thus growing skilled human resources. Mounting demand for integrated/closed peripheral intravenous catheters and growing assumption of safety small and short PIVC are accelerating the market. Rising consciousness about the minimum invasive surgeries integrated and utilizing upgraded materials like Teflon and polytetrafluoroethylene in the product is to foster the market growth during the analysis period.
Key players in the Europe PVIC market profiled in this report are Smith Medical, Terumo Corporation, C. R. Bard, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Tangent Medical, and Vygon Group.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region